Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CNR1 anticorps (Extracellular, N-Term)

Cet anticorps Lapin Polyclonal détecte spécifiquement CNR1 dans WB, IHC, IF, FACS, LCI et IC. Il présente une réactivité avec des échantillons de Rat.
N° du produit ABIN7043023
854,77 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 8 à 9 jours ouvrables

Aperçu rapide pour CNR1 anticorps (Extracellular, N-Term) (ABIN7043023)

Antigène

Voir toutes CNR1 Anticorps
CNR1 (Cannabinoid Receptor 1 (CNR1))

Reactivité

  • 95
  • 44
  • 21
  • 8
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Rat

Hôte

  • 75
  • 14
  • 9
  • 3
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 79
  • 25
Polyclonal

Conjugué

  • 65
  • 6
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CNR1 est non-conjugé

Application

  • 70
  • 37
  • 25
  • 15
  • 13
  • 13
  • 13
  • 10
  • 10
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Live Cell Imaging (LCI), Immunochromatography (IC)
  • Épitope

    • 15
    • 12
    • 10
    • 9
    • 7
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 84-99, Extracellular, N-Term

    Fonction

    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 1

     Réactivité croisée

    Humain, Souris, Rat

    Homologie

    Human - identical, mouse - 15,16 amino acid residues identical

    Attributs du produit

    Anti-Cannabinoid Receptor 1 (extracellular) Antibody (ABIN7043023, ABIN7044155 and ABIN7044156) is a highly specific antibody directed against an epitope of the rat CB1 receptor. The antibody can be used in western blot, immunohistochemistry, and live cell imaging applications. It has been designed to recognize CB1 in human, mouse, and rat samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogène

    NKSLSSFKENEENIQC, corresponding to amino acid residues 84-99 of rat CB1 receptor

    Isotype

    IgG
  • Indications d'application

    WB: 1:200

    FC: 2.5 μg per reaction

    ICC: The optimal concentration should be determined by the user

    IHC: 1:100

    IP: The optimal concentration should be determined by the user

    Commentaires

    Cited Application: IHC

    Negative Control: (ABIN7235028)

    Blocking Peptide: (ABIN7235028)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Concentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Antigène

    CNR1 (Cannabinoid Receptor 1 (CNR1))

    Autre désignation

    CNR1

    Sujet

    Synonyms: CB1, CB-R, CNR1, CB1R, CANN6, Brain-type cannabinoid receptor, Central cannabinoid receptor

    Description: Cannabinoids have been used in Eastern medicine for many years as pain relievers.1 Δ9-tetrahydrocannabinol (THC), the major psychoactive compound in marijuana and hashish, has been shown to interact with two specific cannabinoid receptors: cannabinoid receptor 1 (CB1 receptor) and cannabinoid receptor 2 (CB2 receptor).2 The cannabinoid receptors can be distinguished by their amino acid sequences, signaling mechanisms, and tissue distributions.2 Both receptors belong to the G-protein coupled receptor (GPCR) superfamily. CB1 was shown to modulate several Ca2+ and K+ ion channels.2,3CB1 is primarily expressed in the central nervous system. However, expression of CB1 is also detected in the peripheral terminals, in non-neuronal peripheral tissues such as uterus, testes, spleen, as well as in cells of the immune system.3,4CB1 is implicated in many cellular functions such as neurotransmitter release, pain relief, cancer, and obesity.5,6 Growth inhibition of tumor cells was demonstrated following mixed CB1/CB2 agonist treatment in both prostate and non-melanoma skin cancers.5,6 Through their interaction with CB1, cannabinoid compounds stimulate appetite for sweets and palatable foods in particular, making CB1 an attractive therapeutic target for the treatment of obesity and eating disorders.7

    ID gène

    25248

    NCBI Accession

    NM_001160226

    UniProt

    P20272

    Pathways

    Feeding Behaviour
Vous êtes ici:
Chat with us!